UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response

European journal of neurology, 2021-10, Vol.28 (10), p.3384-3395

2021

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis: clinical aspects

Current opinion in neurology, 2018-12, Vol.31 (6), p.752-759

2018

Link zum Volltext

Verfügbarkeit prüfen

Neurotoxicity‐associated sinus bradycardia after chimeric antigen receptor T‐cell therapy

Hematological oncology, 2022-08, Vol.40 (3), p.482-487

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy

Annals of hematology, 2021-09, Vol.100 (9), p.2303-2310

2021

Link zum Volltext

Verfügbarkeit prüfen

Cognitive impairment in multiple sclerosis: diagnosis and monitoring

Neurological sciences, 2021-12, Vol.42 (12), p.5183-5193

2021

Link zum Volltext

Verfügbarkeit prüfen

Disability progression markers over 6–12 years in interferon-β-treated multiple sclerosis patients

Multiple sclerosis, 2018-03, Vol.24 (3), p.322-330

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients

Journal of neurology, 2022, Vol.269 (1), p.452-459

2022

Link zum Volltext

Verfügbarkeit prüfen

Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score

Neuroradiology, 2021-07, Vol.63 (7), p.1031-1041

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk acceptance in multiple sclerosis patients on natalizumab treatment

PloS one, 2013-12, Vol.8 (12), p.e82796

2013

Link zum Volltext

Verfügbarkeit prüfen

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria

Brain (London, England : 1878), 2018-04, Vol.141 (4), p.1075-1084

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiologically isolated syndrome: 5-year risk for an initial clinical event

PloS one, 2014-03, Vol.9 (3), p.e90509-e90509

2014

Link zum Volltext

Verfügbarkeit prüfen

Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor

Multiple sclerosis, 2018-03, Vol.24 (3), p.301-312

2018

Link zum Volltext

Verfügbarkeit prüfen

Can Cognitive training Reignite Compensatory Mechanisms in Advanced Multiple Sclerosis Patients? An Explorative Morphological Network Approach

Neuroscience, 2022-07, Vol.495, p.86-96

2022

Link zum Volltext

Verfügbarkeit prüfen

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

Neurology, 2016-09, Vol.87 (13), p.1368

2016

Link zum Volltext

Verfügbarkeit prüfen

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes

Multiple sclerosis, 2013-08, Vol.19 (9), p.1175-1181

2013

Link zum Volltext

Verfügbarkeit prüfen

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations

NeuroImage clinical, 2022-01, Vol.34, p.102967-102967, Article 102967

2022

Link zum Volltext

Verfügbarkeit prüfen

Deciphering Multiple Sclerosis Progression

Frontiers in neurology, 2021-04, Vol.12, p.608491-608491

2021

Link zum Volltext

Verfügbarkeit prüfen

Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics

Journal of neuroimaging, 2016-09, Vol.26 (5), p.532-538

2016

Link zum Volltext

Verfügbarkeit prüfen

Detection of lesions in the optic nerve with magnetic resonance imaging using a 3D convolutional neural network

NeuroImage clinical, 2022-01, Vol.36, p.103187-103187, Article 103187

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(96)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(75)
Neurosciences & Neurology
(70)
Clinical Neurology
(58)
Multiple Sclerosis
(56)
Humans
(55)
Neurosciences
(53)
Adult
(31)
Male
(30)
Female
(29)
Neurology
(24)
Magnetic Resonance Imaging
(22)
Middle Aged
(18)
Multiple Sclerosis - Pathology
(17)
Multiple Sclerosis - Diagnostic Imaging
(13)
Neuroimaging
(13)
Medicine
(12)
Prognosis
(12)
Medicine & Public Health
(11)
Prospective Studies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Multiple Sclerosis
(19)
Neurology
(8)
Revista De Neurologiá
(8)
Journal Of Neurology
(7)
Journal Of Neuroimmunology
(5)
Neurology : Neuroimmunology & Neuroinflammation
(5)
Plos One
(4)
Brain
(3)
Multiple Sclerosis Journal
(3)
Neuroimage Clinical
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response

Multiple sclerosis: clinical aspects

Neurotoxicity‐associated sinus bradycardia after chimeric antigen receptor T‐cell therapy

Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple Sclerosis

Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy

Cognitive impairment in multiple sclerosis: diagnosis and monitoring

Disability progression markers over 6–12 years in interferon-β-treated multiple sclerosis patients

Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset

Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI

Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients

Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre

Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score

Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis

Risk acceptance in multiple sclerosis patients on natalizumab treatment

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria

Radiologically isolated syndrome: 5-year risk for an initial clinical event

Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor

Can Cognitive training Reignite Compensatory Mechanisms in Advanced Multiple Sclerosis Patients? An Explorative Morphological Network Approach

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations

Deciphering Multiple Sclerosis Progression

Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics

Detection of lesions in the optic nerve with magnetic resonance imaging using a 3D convolutional neural network

Suchergebnisse filtern